Entrust Global Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-17,000
Closed -$1.25M 13
2022
Q1
$1.25M Buy
+17,000
New +$1.22M 0.43% 14

Other funds holding TDOC

Entrust Global Partners's TDOC Position: Q2 2022 in Review

Entrust Global Partners sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 17,000 shares — an estimated $1.25M sold.

Entrust Global Partners first reported a position in TDOC in Q1 2022 and held it in 1 quarter. The position peaked at $1.25M in Q1 2022. 550 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Entrust Global Partners reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Entrust Global Partners sold 17,000 Teladoc Health shares in Q2 2022, an estimated $1.25M.
  • Entrust Global Partners first reported a position in Teladoc Health in Q1 2022 and held it in 1 quarter.
  • Entrust Global Partners's Teladoc Health position peaked at $1.25M in Q1 2022.
  • 550 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Entrust Global Partners's 13F filing for Q2 2022, filed 12 Aug 2022.